Is lion's mane safe long term?

The dossier a regulator compiles for any botanical, and lion's mane's first two documents: a history of consumption that keeps it outside the novel food regime, and the repeated-dose toxicity studies

Is lion's mane safe long term is a question the supplement shelf answers with a feeling, usually a reassuring one, and the regulators who have to answer the same question for every botanical, additive and novel food on the market answer it with a dossier, and the dossier is the honest method because it names the documents that long-term safety actually consists of. The European safety guidance for botanicals sets out four. A documented history of consumption, which establishes that people have eaten the thing for long enough, in large enough numbers, for a long-term harm to have shown itself if there were one. Repeated-dose toxicity data, which puts the thing into animals every day for a defined period and examines their organs. An exposure assessment, which compares the dose a product delivers against the history, since a history of eating a mushroom on a plate does not cover a concentrated extract at ten times the dose. And contaminant and compositional controls, which address what else arrives with the botanical, from heavy metals to adulterants. A substantial history of safe food use lets the toxicology file be lighter, which is the regime's way of saying that centuries of dinner tell you more than a rat does, and the whole framework is designed to produce a verdict that is conditional and specific rather than general: safe at this dose, in this form, with these controls, for these people. Run lion's mane through the four documents and the verdict comes out with its conditions attached, which is what a verdict should do.

Document one is the strongest in the file. Hericium erinaceus has been eaten as food in China, Japan and Korea for centuries, prized as a delicacy with a texture compared to seafood, cooked fresh and dried and eaten daily in season by populations large enough that an acute or common chronic harm would be known, and it has no such reputation; it was consumed in the European Union before 1997, which keeps the fruiting body outside the EU's novel food regime and means it can be sold as a food and a food supplement without the pre-market authorisation a genuinely new ingredient would need. Mycelium grown on grain and certain extracts have a less clear status, which is one of several reasons the fruiting body is the form the dossier covers best. Document two is the repeated-dose toxicology, and it exists: rodents were given lion's mane fruiting body or extract by mouth every day for 28 days and for 90 days at doses scaled up to grams per kilogram of body weight, which for a human would be hundreds of grams of mushroom a day, with liver and kidney markers, blood counts, organ weights and tissue histology examined at the end, and no treatment-related change was found at any dose. A 90-day study is the standard subchronic study the frameworks ask for, and it sets a no-observed-adverse-effect level at the top of the tested range, two orders of magnitude and more above any supplement dose, which is a food's margin rather than a drug's and agrees with document one. Two documents in, the dossier reads like the dossier of a vegetable.

Documents three and four, exposure and contaminants, where the dossier's conditions live, the human record that supplements it, the verdict with its conditions, and the honest buy

Document three is exposure, and it is where the trade's habits start to matter, because a history of eating a mushroom covers a plate and not a scoop. A portion of fresh lion's mane, 100 to 150g, is about 10 to 15g of dry matter; a 5:1 fruiting body extract at one capsule a day delivers about 300mg of extract representing 1500mg of dried mushroom, which sits comfortably inside what a plate supplies and is the exposure the history of consumption actually covers. The trade's larger doses push past it: two to three grams of extract a day, the regime some powders and stacks encourage, represents ten to fifteen grams of dried mushroom daily, every day, year round, which no culinary history covers, and the sixteen-week trial's 3g of powder, about 3g of dried mushroom, sits between the two. The exposure document therefore returns a conditional verdict of its own: a capsule at a food-equivalent dose is inside the history, and a multi-gram daily powder habit is an exposure the dossier has not seen, covered by the toxicology margin but not by the centuries. Document four is contaminants, and it is the document a buyer has to obtain for themselves, because it is specific to the batch rather than to the species. Fungi concentrate cadmium and other heavy metals from the substrate they grow on more efficiently than plants, cadmium accumulates in the human kidney with a half-life of ten to thirty years, and the EU sets contaminant limits for exactly this reason; a lion's mane product grown on clean substrate and tested per batch against those limits has satisfied the fourth document, and a product without a certificate has not, whatever its label says. For a daily habit over years, document four is the whole of the long-term question, since the fungus itself has no mechanism of accumulation and its substrate does.

The human record supplements the dossier without replacing it. Sixteen weeks of randomised trial in thirty older adults at 3g a day recorded no serious adverse events and normal liver and kidney bloods; a young-adult pilot recorded mild digestive complaints at most; the clinical case report literature contains a small number of allergic reactions and no organ injury after two decades of mass-market use; and no tolerance, dependence or withdrawal has been described, since there is no receptor to adapt and the trial's cognitive scale simply reversed in the washout. The dossier's verdict, with its conditions, reads as a regulator would write it: lion's mane fruiting body is safe for long-term use at a food-equivalent dose, in a product tested per batch for heavy metals, by healthy adults, with the exposure condition against multi-gram daily powders, the contaminant condition against untested products, and the standing exclusions for pregnancy and breastfeeding, where no document covers them, fungal allergy, under-18s, and a pharmacist conversation first for anyone on anticoagulant, antiplatelet, diabetes or immunosuppressant medication, with a stop one to two weeks before surgery. Beyond sixteen weeks there is no trial, so the verdict rests on documents one, two and four rather than on a human study, which is the position of almost every food on a plate and a stronger one than almost any botanical on the shelf. The honest buy is the product that puts three of the four documents on its label and makes the fourth available: the worked example, {FLLM}, is fruiting body, so document one applies; one capsule a day of a 5:1 extract labelled 1500mg mushroom equivalent, so document three sits inside the plate; UK made under GMP and BRC and independently lab tested per batch, so document four is answered on request; 120 days for £15.49 at 13p, and nothing on the label about safety because the dossier says it with conditions, and a label cannot.

What to check on the label

Questions people also ask

Is lion's mane safe for long term use?

By the dossier a regulator would compile, yes with conditions: centuries of culinary consumption that keep the fruiting body outside the novel food regime, 90-day rodent toxicology at grams per kilogram with no organ change, an exposure from one extract capsule that sits inside what a plate supplies, and a contaminant condition, since fungi concentrate cadmium and the kidney stores it for decades, met by a per-batch certificate; the human record adds sixteen clean weeks, and the exclusions for pregnancy, breastfeeding, fungal allergy, under-18s and three medication classes stand.

Has lion's mane been studied long term in humans?

No; sixteen weeks is the longest randomised trial, in thirty older adults at 3g a day with no serious adverse events and normal liver and kidney bloods, and nothing has been run for six months or a year in any population; the long-term verdict therefore rests on the history of consumption, the repeated-dose toxicology and the contaminant controls rather than on a human study, which is the position of almost every food on a plate and a stronger one than almost any botanical on the shelf.

Does lion's mane build up in the body over time?

The fungus does not: its beta-glucans are fermented and excreted, its protein is digested, its hericenones are present in milligram amounts with no tissue store, and there is no receptor to adapt or withdraw from; what can build up is cadmium from the substrate, which fungi concentrate and the kidney holds with a half-life of ten to thirty years, so the accumulation question belongs to the batch certificate and a product tested per batch against the EU's limits has answered it.

Is it safe to take high doses of lion's mane long term?

The dossier's exposure document is where high doses lose their cover: a culinary history covers a plate, which one extract capsule sits inside, but two to three grams of extract a day represents ten to fifteen grams of dried mushroom daily year round, which no food history covers and only the toxicology margin protects; the 90-day studies at grams per kilogram say it is unlikely to harm, the history says nobody has lived that way, and the honest position is to keep a long-term habit at a food-equivalent dose.

Who should not take lion's mane long term?

The same groups who should not take it short term: pregnant and breastfeeding women, because no document in the dossier covers them; anyone with a fungal or mould allergy, since the mushroom's one real acute reaction is allergic; anyone under eighteen; and, for a pharmacist conversation first rather than a prohibition, anyone on anticoagulant or antiplatelet, diabetes or immunosuppressant medication, with a stop one to two weeks before surgery; anyone with reduced kidney function should clear it with their renal team because of the cadmium question.

Sources

1. The EFSA guidance on the safety assessment of botanicals: a botanical's long-term safety is judged on documented history of consumption, repeated-dose toxicity data, the exposure a product delivers against that history, and contaminant and compositional controls, with a substantial history of safe food use allowing a lighter toxicological dossier. https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2009.1249
2. UK and EU novel food status for Hericium erinaceus: the fruiting body has a documented history of consumption as a food before 1997 and is not novel, while some mycelium-derived preparations have been queried under the novel food rules, a status question about the preparation rather than the species. https://www.gov.uk/guidance/novel-foods-authorisation-guidance
3. The Hericium erinaceus toxicology studies: repeated-dose oral studies in rodents over 28 and 90 days at doses of grams per kilogram of body weight found no treatment-related changes in liver enzymes, organ weights or histology, giving no-observed-adverse-effect levels far above the human equivalent of any supplement dose. PubMed record
4. UK and retained EU contaminant law: maximum levels for lead, cadmium, mercury and arsenic in food supplements are set in legislation, with certain fungus-based supplements holding specific cadmium limits. https://www.legislation.gov.uk/eur/2006/1881/contents

Related answers

• Can you take lion's mane long term?
• How much lion's mane is safe to take a day?
• Is 4000 mg of lion's mane safe?
• Is it safe to take lion's mane daily?
• How long does it take for lion's mane to work for memory?
• How long does lion's mane take to work for anxiety?